St. Jude Medical launches Ilumien Optis in Japan
St. Jude Medical reveals the Japanese launch of its Ilumien Optis device, designed to indicate the state and severity of coronary lesions during stent procedures.
St. Jude Medical (NYSE:STJ) said its launched the Ilumien Optis device in Japan, calling it the only medical device on the market to combine fractional flow reserve and optical coherence tomography technology to allow doctors to evaluate the state and severity of coronary lesions.
The St. Paul, Minn.-based medical device company said the Ilumien Optis combines its PressureWire Aeris wireless FFR technology with its Dragonfly JP imaging catheter. The FFR tech measures the flow of blood across lesions in the arteries that feed the heart muscle, so that cardiologists can determine whether a stent is needed.
The OCT tech uses near-infrared light to provide images of the lesions, according to a press release.